Home » Newsletters » BioWorld Science

BioWorld Science

April 25, 2001

View Archived Issues

Elan reports advances in product portfolio in first quarter

Senetek's Invicorp well tolerated for ED in hypertensive patients

Continuing success of double transplant procedure demonstrated by BioTransplant and MGH

Donepezil highlighted at Progress in Alzheimer's and Parkinson's Disease meeting

Antigenics to acquire Aronex; broadens product portfolio

PowderJect's hepatitis B DNA vaccine elicits high immunogenicity in nonresponders

Animal studies support potential of KW-6002 in PD, both alone and with dopaminergic drugs

New safety and efficacy data submitted to support anakinra BLA

Genentech highlights Q1 2001 progress

Active Biotech successfully completes phase I trial of SAIK-MS compound

In vitro data described in Stuttgart for Slovakofarma's investigational ACAT inhibitor

m-phasys enters three important drug discovery alliances

Starpharma develops second-generation antiviral dendrimers for STDs

New series of human HIV-1 RT inhibitors presented at Antiviral Research conference

Modex Therapeutics progresses in phase II clinical evaluation of EpiDex

Nanomolar anti-HIV activity discovered in new series of reverse transcriptase inhibitors

TNFerade expected to have wide safety margin in humans based on murine data

Intranasal proteosome influenza vaccine shows positive safety and tolerability profile in humans

Prodrug of beta-L-dC with improved oral bioavailability and systemic delivery

Temporary suspension of phase II trials of INS-365 in bronchitis announced

HGS discovers new human protein termed PGRP-L

Novel polypeptide and use in diagnosis, treatment of cancer

New beta-lactamase inhibitors in development at GSK for use in Rx of bacterial infections

Recent patent covers new selective beta3-adrenoceptor agonists synthesized at Sanofi-Synthelabo

Abbott discloses sulfonylphenylpyrazole COX-2 inhibitors

PPAR modulators discovered as part of Lilly/Ligand collaboration

NPS presents new calcium receptor modulators and their use

Identification of selective Y5 receptor antagonists described by Synaptic team

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026